Wednesday, November 23, 2016

BRIEF-Ceapro qtrly earnings per share $0.01

* Will "commence patient recruitment for pilot clinical

study to develop beta glucan as a cholesterol reducer in Q1

2017"

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)